BINEX Co., Ltd.

₩5,910As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:053030Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.91%)
Div yield —
ROE (16.88%)
Medical (Pharmaceuticals)
Beta (5Y) 0.65
PE TTM —
TSR TTM (62.88%)
Mkt cap ₩188.2B
ROIC (9.54%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩7,132
20.68%
(95.15%)
Buy 8|9|2|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
95.06
106.09
101.79
108.04
22.86%
25.84%
17.82%
19.60%
Revenue₩B
9.261
9.494
9.829
9.623
5.01%
7.65%
6.08%
5.35%
Peers (US$138.8M)
Cap (US$)
PE
169.2M
10.20x
45.64M
144.1x
138.1M
8.495x
Capital
TTM
5Y
10Y
Leveragex
0.253
0.152
0.130
EBIT/Intx
0.407
0.161
0.200
Own earn%
16.54
(35.99)
(15.34)
Sh yield%
19.31
15.75
16.08
Owners
Insiders/Inst%
10.25
57.07
Short interest%
2.06
SBC / revenue%
1.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–2
$1 testx
−0.1
Incr. ROIC%
4